Platinum Equity announces the acquisition of a controlling stake in Inventia Healthcare Limited’s core Oral Solid Dosage (“OSD”) business (“Inventia”) from India Life Sciences Fund III (Advised by InvAscent), NYLIM Jacob Ballas India Fund III, LLC, Mauritius and affiliates of the company’s founding Shah family (collectively, the “Sellers”). Headquartered in Mumbai, Inventia was jointly founded in 1985 by the company’s late chairman and managing director Janak Shah and executive director Maya Shah. Today, Inventia serves as a partner to over 100 customers supplying both semi-finished and finished OSD formulations for both regular and value-added generics.
Read the full article: Platinum Equity Acquires Controlling Stake in Inventia Healthcare //
Source: https://www.prnewswire.com/news-releases/platinum-equity-acquires-controlling-stake-in-inventia-healthcare-302234641.html